About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7

NCT00000358·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

National Institute on Drug Abuse (NIDA)

With

University of Pennsylvania

Age

21–59

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Please contact site for information.

The record

StatusCompleted

PhasePhase 1

Taking part0

Started—

UpdatedJan 12, 2017

Conditions

Opioid-Related Disorders Substance-Related Disorders

Where1

University of Pennsylvania
Philadelphia, Pennsylvania, United States

Clareo Health | Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7